Ameliorating effects of curcumin on 6-OHDA-induced dopaminergic denervation, glial response, and SOD1 reduction in the striatum of hemiparkinsonian mice

European Review for Medical and Pharmacological Sciences

Volumn 17, Issue 10, 2013, Pages 1360-1368

  Tripanichkul, W ^a   Jaroensuppaperch, E O ^a  

^a SRINAKHARINWIROT UNIVERSITY   (Thailand)

Author keywords

6 OHDA; Astrocyte; Curcumin; Microglia; Nigrostriatal dopaminergic axon; SOD1

Indexed keywords

CALCIUM BINDING PROTEIN; CALCIUM BINDING PROTEIN IBA1; COPPER ZINC SUPEROXIDE DISMUTASE; CURCUMIN; GLIAL FIBRILLARY ACIDIC PROTEIN; OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONTROLLED STUDY; CORPUS STRIATUM; DENERVATION; DOPAMINERGIC ACTIVITY; GLIA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MICROGLIA; MOUSE; NONHUMAN; PARKINSONISM; PROTEIN EXPRESSION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CORPUS STRIATUM; CURCUMIN; MALE; MICE; MICE, INBRED ICR; NEUROGLIA; NEUROPROTECTIVE AGENTS; OXIDOPAMINE; PARKINSON DISEASE; SUPEROXIDE DISMUTASE; TYROSINE 3-MONOOXYGENASE;

EID: 84878621998     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. LIBERATORE GT, JACKSON-LEWIS V, VUKOSAVIC S, MANDIR AS, VILA M, MCAULIFFE WG, DAWSON VL, DAWSON TM, PRZEDBORSKI S. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nat Med 1999; 5: 1403-1409.
2. MCGEER PL, ITAGAKI S, AKIYAMA H, MCGEER EG. Rate of cell death in parkinsonism indicates active neuropathological process. Ann Neurol 1988; 24: 574-576.
3. WU DC, JACKSON-LEWIS V, VILA M, TIEU K, TEISMANN P, VADSETH C, CHOI DK, ISCHIROPOULOS H, PRZEDBORSKI S. Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J Neurosci 2002; 22: 1763-1771.
4. KNOTT C, STERN G, WILKIN GP. Inflammatory regulators in Parkinson's disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2. Mol Cell Neurosci 2000; 16: 724-739.
5. NORENBERG MD. Reactive astrocytosis. In: Michael Aschner and Harold K. Kimelberg, editors. The role of glia in neurotoxicity. Boca Raton (FL): CRC Press 1996; pp. 93-107.
6. TATEISHI N, MORI T, KAGAMIISHI Y, SATOH S, KATSUBE N, MORIKAWA E, MORIMOTO T, MATSUI T, ASANO T. Astrocytic activation and delayed infarct expansion after permanent focal ischemia in rats. Part II: suppression of astrocytic activation by a novel agent (R)-(-)-2-propyloctanoic acid (ONO-2506) leads to mitigation of delayed infarct expansion and early improvement of neurologic deficits. J Cereb Blood Flow Metab 2002; 22: 723-734.
7. AMBANI LM, VAN WOERT MH, MURPHY S. Brain peroxidase and catalase in Parkinson disease. Arch Neurol 1975; 32: 114-118.
8. DEXTER DT, CARTER CJ, WELLS FR, JAVOY-AGID F, AGID Y, LEES A, JENNER P, MARSDEN CD. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J Neurochem 1989; 52: 381-389.
9. GOOD PF, OLANOW CW, PERL DP. Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study. Brain Res 1992; 593: 343-346.
10. PERRY TL, GODIN DV, HANSEN S. Parkinson's disease: a disorder due to nigral glutathione deficiency? Neurosci Lett 1982; 33: 305-310.
11. WARNER DS, SHENG H, BATINIC-HABERLE I. Oxidants, antioxidants and the ischemic brain. J Exp Biol 2004; 207: 3221-3231.
12. BANNISTER JV, CALABRESE L. Assays for superoxide dismutase. Methods Biochem Anal 1987; 32: 279-312.
13. OKADO-MATSUMOTO A, FRIDOVICH I. Subcellular distribution of superoxide dismutases (SOD) in rat liver: Cu,Zn-SOD in mitochondria. J Biol Chem 2001; 276: 38388-38393.
14. ASANUMA M, HIRATA H, CADET JL. Attenuation of 6- hydroxydopamine-induced dopaminergic nigrostriatal lesions in superoxide dismutase transgenic mice. Neuroscience 1998; 85: 907-917.
15. PRZEDBORSKI S, KOSTIC V, JACKSON-LEWIS V, NAINI AB, SIMONETTI S, FAHN S, CARLSON E, EPSTEIN CJ, CADET JL. Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced neurotoxicity. J Neurosci 1992; 12: 1658-1667.
16. ZHANG J, GRAHAM DG, MONTINE TJ, HO YS. Enhanced N-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine toxicity in mice deficient in CuZn-superoxide dismutase or glutathione peroxidase. J Neuropathol Exp Neurol 2000; 59: 53-61.
17. FRAUTSCHY SA, HU W, KIM P, MILLER SA, CHU T, HARRISWHITE ME, COLE GM. Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology. Neurobiol Aging 2001; 22: 993-1005.
18. THIYAGARAJAN M, SHARMA SS. Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats. Life Sci 2004; 74: 969-985.
19. WU A, YING Z, GOMEZ-PINILLA F. Dietary curcumin counteracts the outcome of traumatic brain injury on oxidative stress, synaptic plasticity, and cognition. Exp Neurol 2006; 197: 309-317.
20. TRIPANICHKUL W, JAROENSUPPAPERCH EO. Curcumin protects nigrostriatal dopaminergic neurons and reduces glial activation in 6-hydroxydopamine hemiparkinsonian mice model. Int J Neurosci 2012; 122: 263-270.
21. FRANKLIN KBJ, PAXINOS G. The Mouse Brain in the Stereotaxic Coordinates. San Diego: Academic Press, 1997.
22. ZBARSKY V, DATLA KP, PARKAR S, RAI DK, ARUOMA OI, DEXTER DT. Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease. Free Radic Res 2005; 39: 1119-1125.
23. XU Y, KU BS, YAO HY, LIN YH, MA X, ZHANG YH, LI XJ. The effects of curcumin on depressive-like behaviors in mice. Eur J Pharmacol 2005; 518: 40-46.
24. WANG J, DU XX, JIANG H, XIE JX. Curcumin attenuates 6-hydroxydopamine- induced cytotoxicity by anti-oxidation and nuclear factor-kappa B modulation in MES23.5 cells. Biochem Pharmacol 2009; 78: 178-183.
25. YU S, ZHENG W, XIN N, CHI ZH, WANG NQ, NIE YX, FENG WY, WANG ZY. Curcumin prevents dopaminergic neuronal death through inhibition of the c-Jun N-terminal kinase pathway. Rejuvenation Res 2010; 13: 55-64.
26. CHEN J, TANG XQ, ZHI JL, CUI Y, YU HM, TANG EH, SUN SN, FENG JQ, CHEN PX. Curcumin protects PC12 cells against 1-methyl-4-phenylpyridinium ion-induced apoptosis by bcl-2-mitochondria-ROS-iNOS pathway. Apoptosis 2006; 11: 943-953.
27. GEHRMANN J, SCHOEN SW, KREUTZBERG GW. Lesion of the rat entorhinal cortex leads to a rapid microglial reaction in the dentate gyrus. A light and electron microscopical study. Acta Neuropathol 1991; 82: 442-455.
28. JENSEN MB, GONZALEZ B, CASTELLANO B, ZIMMER J. Microglial and astroglial reactions to anterograde axonal degeneration: a histochemical and immunocytochemical study of the adult rat fascia dentata after entorhinal perforant path lesions. Exp Brain Res 1994; 98: 245-260.
29. SHENG JG, SHIRABE S, NISHIYAMA N, SCHWARTZ JP. Alterations in striatal glial fibrillary acidic protein expression in response to 6-hydroxydopamine- induced denervation. Exp Brain Res 1993; 95: 450-456.
30. STREIT WJ, KREUTZBERG GW. Response of endogenous glial cells to motor neuron degeneration induced by toxic ricin. J Comp Neurol 1988; 268: 248-263.
31. HE Y, APPEL S, LE W. Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum. Brain Res 2001; 909: 187-193.
32. BANATI RB, GEHRMANN J, SCHUBERT P, KREUTZBERG GW. Cytotoxicity of microglia. Glia 1993; 7: 111-118.
33. BOTCHKINA GI, MEISTRELL ME, 3RD, BOTCHKINA IL, TRACEY KJ. Expression of TNF and TNF receptors (p55 and p75) in the rat brain after focal cerebral ischemia. Mol Med 1997; 3: 765-781.
34. LAU LT, YU AC. Astrocytes produce and release interleukin-1, interleukin-6, tumor necrosis factor alpha and interferon-gamma following traumatic and metabolic injury. J Neurotrauma 2001; 18: 351-359.
35. ORZYLOWSKA O, ODERFELD-NOWAK B, ZAREMBA M, JANUSZEWSKI S, MOSSAKOWSKI M. Prolonged and concomitant induction of astroglial immunoreactivity of interleukin-1beta and interleukin-6 in the rat hippocampus after transient global ischemia. Neurosci Lett 1999; 263: 72-76.
36. AMBEGAOKAR SS, WU L, ALAMSHAHI K, LAU J, JAZAYERI L, CHAN S, KHANNA P, HSIEH E, TIMIRAS PS. Curcumin inhibits dose-dependently and time-dependently neuroglial cell proliferation and growth. Neuro Endocrinol Lett 2003; 24: 469-473.
37. LIN MS, LEE YH, CHIU WT, HUNG KS. Curcumin Provides Neuroprotection After Spinal Cord Injury. J Surg Res 2009; 166: 280-289.
38. YANG S, ZHANG D, YANG Z, HU X, QIAN S, LIU J, WILSON B, BLOCK M, HONG JS. Curcumin protects dopaminergic neuron against LPS induced neurotoxicity in primary rat neuron/glia culture. Neurochem Res 2008; 33: 2044-2053.
39. ZHANG LJ, WU CF, MENG XL, YUAN D, CAI XD, WANG QL, YANG JY. Comparison of inhibitory potency of three different curcuminoid pigments on nitric oxide and tumor necrosis factor production of rat primary microglia induced by lipopolysaccharide. Neurosci Lett 2008; 447: 48-53.
40. AHMAD M, YOUSUF S, KHAN MB, AHMAD AS, SALEEM S, HODA MN, ISLAM F. Protective effects of ethanolic extract of Delphinium denudatum in a rat model of Parkinson's disease. Hum Exp Toxicol 2006; 25: 361-368.
41. KHAN MM, AHMAD A, ISHRAT T, KHAN MB, HODA MN, KHUWAJA G, RAZA SS, KHAN A, JAVED H, VAIBHAV K, ISLAM F. Resveratrol attenuates 6-hydroxydopamineinduced oxidative damage and dopamine depletion in rat model of Parkinson's disease. Brain Res 2010; 1328: 139-151.
42. KUMAR R, AGARWAL AK, SETH PK. Free radical-generated neurotoxicity of 6-hydroxydopamine. J Neurochem 1995; 64: 1703-1707.
43. KUNIKOWSKA G, JENNER P. 6-Hydroxydopaminelesioning of the nigrostriatal pathway in rats alters basal ganglia mRNA for copper, zinc- and manganese-superoxide dismutase, but not glutathione peroxidase. Brain Res 2001; 922: 51-64.
44. PERUMAL AS, GOPAL VB, TORDZRO WK, COOPER TB, CADET JL. Vitamin E attenuates the toxic effects of 6-hydroxydopamine on free radical scavenging systems in rat brain. Brain Res Bull 1992; 29: 699-701.
45. SCHOBER A. Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP. Cell Tissue Res 2004; 318: 215-224.
46. THIRUCHELVAM M, PROKOPENKO O, CORY-SLECHTA DA, BUCKLEY B, MIROCHNITCHENKO O. Overexpression of superoxide dismutase or glutathione peroxidase protects against the paraquat + maneb-induced Parkinson disease phenotype. J Biol Chem 2005; 280: 22530-22539.
47. LIM GP, CHU T, YANG F, BEECH W, FRAUTSCHY SA, COLE GM. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci 2001; 21: 8370-8377.
48. CANALES-AGUIRRE AA, GOMEZ-PINEDO UA, LUQUIN S, RAMIREZ-HERRERA MA, MENDOZA-MAGANA ML, FERIAVELASCO A. Curcumin protects against the oxidative damage induced by the pesticide parathion in the hippocampus of the rat brain. Nutr Neurosci 2012; 15: 62-69.
49. KUO CP, LU CH, WEN LL, CHERNG CH, WONG CS, BOREL CO, JU DT, CHEN CM, WU CT. Neuroprotective effect of curcumin in an experimental rat model of subarachnoid hemorrhage. Anesthesiology 2011; 115: 1229-1238.
50. AL-OMAR FA, NAGI MN, ABDULGADIR MM, AL JONI KS, AL-MAJED AA. Immediate and delayed treatments with curcumin prevents forebrain ischemia-induced neuronal damage and oxidative insult in the rat hippocampus. Neurochem Res 2006; 31: 611-618.